BIONUTRICS INC
SC 13G, 1998-02-17
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: CURAGEN CORP, S-1/A, 1998-02-17
Next: PEREGRINE SYSTEMS INC, 10-Q, 1998-02-17



<PAGE>   1
                                                  ------------------------------
                                                          OMB Approval
                                                  ------------------------------
                                                  OMB Number:          3235-0145
                                                  Expires:      October 31, 1994
                                                  Estimated average burden
                                                  hours per response ....  14.90
                                                  ------------------------------



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13G

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934

                        (AMENDMENT NO. ________________)*

                                BIONUTRICS, INC.
- --------------------------------------------------------------------------------
                                (Name of Issuer)

                                  COMMON STOCK
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                   090946 10 4
                    ----------------------------------------
                                 (CUSIP Number)

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 (the "Act") or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>   2
- ---------------------------                          --------------------------
CUSIP No.   090946 10 4              13G             Page  2   of   6     Pages
- ---------------------------                          --------------------------

- --------------------------------------------------------------------------------
1      NAME OF REPORTING PERSON
       S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

       RICHARD M. FELDHEIM
- --------------------------------------------------------------------------------
2      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*           (a) / /
                                                                   (b) / /

- --------------------------------------------------------------------------------
3      SEC USE ONLY

- --------------------------------------------------------------------------------
4      CITIZENSHIP OR PLACE OF ORGANIZATION

       U.S.
- --------------------------------------------------------------------------------
    NUMBER OF      5     SOLE VOTING POWER
     SHARES
  BENEFICIALLY             3,333
    OWNED BY       -------------------------------------------------------------
      EACH          6     SHARED VOTING POWER
    REPORTING
     PERSON               4,180,101
      WITH         -------------------------------------------------------------
                    7     SOLE DISPOSITIVE POWER

                            3,333
                   -------------------------------------------------------------
                    8     SHARED DISPOSITIVE POWER

                          4,180,101
- --------------------------------------------------------------------------------
9      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

       4,183,434
- --------------------------------------------------------------------------------
10     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*/ /

- --------------------------------------------------------------------------------
11     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

       23.37%
- --------------------------------------------------------------------------------
12     TYPE OF REPORTING PERSON*

       IN
- --------------------------------------------------------------------------------
<PAGE>   3
                                                               Page 3 of 6 Pages

ITEM 1.

      (a)   Name of Issuer  - BIONUTRICS, INC.

      (b)   Address of Issuer's Principal Executive Offices

                  2425 EAST CAMELBACK ROAD, SUITE 650
                  PHOENIX, ARIZONA  85016

ITEM 2.

      (a)   Name of Person Filing  - RICHARD M. FELDHEIM

      (b)   Address of Principal Business Office or, if none, Residence

                  8320 NO. HAYDEN ROAD, SUITE B110-A
                  SCOTTSDALE, ARIZONA  85281

      (c)   Citizenship or Place of Organization - U.S.

      (d)   Title of Class of Securities - COMMON STOCK

      (e)   CUSIP Number - 090946 10 4

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b), CHECK
WHETHER THE PERSON FILING IS A:

      (a)  / /   Broker or Dealer registered under Section 15 of the Act

      (b)  / /   Bank as defined in section 3(a)(6) of the Act

      (c)  / /   Insurance Company as defined in section 3(a)(19) of the Act

      (d)  / /   Investment Company registered under section 8 of the Investment
                 Company Act

      (e)  / /   Investment Adviser registered under section 203 of the
                 Investment Advisers Act of 1940

      (f)  / /   Employee Benefit Plan, Pension Fund which is subject to the
                 provisions of the Employee Retirement Income Security Act of
                 1974 or Endowment Fund; see Section 240.13d-1(b)(1)(ii)(F)

      (g)  / /   Parent Holding Company, in accordance with
                 Section 240.13d-1(b)(ii)(G)

      (h)  / /   Group, in accordance with Section 240.13d-1(b)(1)(ii)(H)
<PAGE>   4
                                                               Page 4 of 6 Pages

ITEM 4.  OWNERSHIP

      If the percent of the class owned, as of December 31 of the year covered
by the statement, or as of the last day of any month described in Rule
13d-1(b)(2), if applicable, exceeds five percent, provide the following
information as of that date and identify those shares which there is a right to
acquire.

      (a)   Amount Beneficially Owned - 4,183,434

      (b)   Percent of Class - 23.37%

      (c)   Number of shares as to which such person has:

            (i)   sole power to vote or to direct the vote - 3,333

            (ii)  shared power to vote or to direct the vote - 4,180,101

            (iii) sole power to dispose or to direct the disposition of - 3,333

            (iv)  shared power to dispose or to direct the disposition of -
                  4,180,101

      The amount of shares set forth above include 3,333 shares issuable upon
exercise of options.

      The amount of shares set forth above includes 133,280 shares held by
Millrich Corporation, 19,826 held by Abby's, Inc., both of which are
corporations controlled by Mr. Feldheim. Also includes 395,076 shares held by
the RM Feldheim Limited Partnership of which Mr. Feldheim is a general partner.
Includes 3,631,919 shares held by the RH Lane Limited Partnership of which Mr.
Feldheim is a general partner and over which he shares voting power.

      Mr. Feldheim disclaims beneficial ownership of all shares held by Abby's
Inc., Millrich Corporation, RM Feldheim Limited Partnership and RH Lane Limited
Partnership except to the extent that his individual interest in such shares
arises from his interest in each such entity.

ITEM 5.  OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

      If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following / /.

ITEM 6.  OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

      If any other person is known to have the right to receive or the power to
direct the receipt of dividends from, or the proceeds from the sale of, such
securities, a statement to that effect should be included in response to this
item and, if such interest relates to more than five percent of the class, such
person should be identified. A listing of the shareholders of an investment
company registered under the Investment Company Act of 1940 or the beneficiaries
of employee benefit plan, pension fund or endowment fund is not required.

      The limited and general partners of the R.H. Lane Limited Partnership (the
"Partnership") have the right to receive dividends and sale proceeds from the
shares held by the Partnership. Mr. & Mrs. Ronald Lane each have an interest in
more than 5% of the outstanding shares through their interest in the
Partnership.

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
        SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

            NOT APPLICABLE
<PAGE>   5
                                                               Page 5 of 6 Pages

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

            NOT APPLICABLE

ITEM 9. NOTICE OF DISSOLUTION OF GROUP

            NOT APPLICABLE

ITEM 10. CERTIFICATION

            NOT APPLICABLE
<PAGE>   6
                                                               Page 6 of 6 Pages


                                    SIGNATURE

      After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.


                                     2/16/98
                    ---------------------------------------
                                      Date

                           /s/ Richard M. Feldheim
                    ---------------------------------------
                                    Signature



                               Richard M. Feldheim
                    ---------------------------------------
                                   Name/Title




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission